<DOC>
	<DOC>NCT00329615</DOC>
	<brief_summary>The study is designed to evaluate whether daily insulin treatment to weight losing cancer patients attenuates progression of cancer cachexia and improves metabolism.</brief_summary>
	<brief_title>Insulin Treatment in Cancer Cachexia</brief_title>
	<detailed_description>Randomized study with long-term follow-up based on survival, health related quality of life, food intake, resting energy expenditure, body composition, exercise capacity and measurement of metabolic efficiency.</detailed_description>
	<mesh_term>Cachexia</mesh_term>
	<mesh_term>Isophane Insulin, Human</mesh_term>
	<criteria>Weight loss Systemic solid cancer Diabetes Brain metastases Expectant survival of less than 6 months Serum creatinine above 200 umol/l Persistent of recurrent fever Cholestasis</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Cancer cachexia</keyword>
	<keyword>Tumor host metabolism</keyword>
</DOC>